Metformin-induced cholangiohepatitis
- 1Case Western Reserve University @ MetroHealth Medical Center, Hospital Medicine, 2500 MetroHealth Dr, Cleveland, Ohio, 44138, USA
- 2Gastroenterology of Canton Inc, 4124 Munson Rd NW, Canton, Ohio, 44718, USA
- 3Mercy Medical Center, 1320 Mercy Dr NW, Canton, Ohio, 44708, USA
- 4NEOUCOM, Gastroenterology, Gastroenterology of Canton Inc, 4124 Munson St NW, Canton, Ohio, 44718, USA
- Raja Shekhar Reddy Sappati Biyyani, rsappati{at}hotmail.com
- Published 14 July 2009
Summary
Drug-induced cholangiohepatitis accounts for 20–50% of non-viral chronic hepatitis cases. Metformin is the most commonly prescribed oral anti-diabetic drug from the biguanide class used in treatment of overweight and obese type 2 diabetes mellitus patients. Metformin-induced cholangiohepatitis with marked elevations in serum liver transaminases and intrahepatic cholestasis has been infrequently reported. Here, we report a case of acute cholangiohepatitis after initiation of metformin treatment.
Footnotes
-
Competing interests: none.








